Table 1.
Demographic characteristics of patients
| Characteristics | |
|---|---|
| Patients, n | 22 |
| Male (%) | 16 (72.7) |
| Female (%) | 6 (27.3) |
| Diagnosis | |
| DLBCL (%) | 15 (68.2) |
| tFL (%) | 5 (22.7) |
| PMBCL (%) | 2 (9.1) |
| Reinfused product | |
| Tisagenlecleucel (%) | 17 (77.3) |
| Axicabtagene ciloleucel (%) | 5 (22.7) |
| Prior treatment lines, median (range) | 4 (2–6) |
| bone marrow infiltration, n (%) | 17 (77.3) |
| LDH at LD, median (range) | 277 (198–1542) |
| ≤ ULN (213 U/l) (%) | 3 (13.6) |
| > ULN (213 U/l) (%) | 19 (86.4) |
DLBCL diffuse large B-cell lymphoma, tFL transformed follicular lymphoma, PMBCL primary mediastinal B-cell lymphoma, LDH lactate dehydrogenase, LD lymphodepletion, ULN upper level of normal